HomeARTL • NASDAQ
add
Artelo Biosciences Inc
Previous close
$1.42
Day range
$1.33 - $1.45
Year range
$1.15 - $2.98
Market cap
4.68M USD
Avg Volume
160.92K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.59M | 12.96% |
Net income | -2.48M | -14.53% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 7.61M | -50.86% |
Total assets | 10.35M | -43.97% |
Total liabilities | 817.00K | -2.74% |
Total equity | 9.54M | — |
Shares outstanding | 3.23M | — |
Price to book | 0.48 | — |
Return on assets | -55.33% | — |
Return on capital | -60.38% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -2.48M | -14.53% |
Cash from operations | -2.94M | -34.58% |
Cash from investing | 1.27M | -42.29% |
Cash from financing | 55.00K | — |
Net change in cash | -1.62M | -5,885.71% |
Free cash flow | -2.01M | -47.39% |
About
Founded
May 2, 2011
Headquarters
Website
Employees
5